Meet the Start-ups! Bridging Science and Business: Experiences in Commercialising Research
What does it take to turn breakthrough research into real-world ventures?
Nucleate Singapore, in collaboration with NUS MBA, invites you to an evening that brings together researchers, clinicians, MBA students, and aspiring founders to explore the journey from academic discovery to real-world commercialisation.
Hear from leaders who have successfully navigated the transition from research to venture creation as they share candid insights on translating science into impact.
The session will feature a moderated discussion followed by networking with peers across science, healthcare, and business
Whether you come from a research or business background, this session offers a practical look at how ideas move from discovery to deployment.
Speakers:
Dr. Lynne Lim, Founder & CEO, NousQ
Dr. Lynne Lim is an ENT surgeon and medtech entrepreneur who transitioned from academic medicine to founding NousQ, a hearing technology startup. She will share practical insights on translating clinical innovation into a venture and navigating the realities of commercialization.
Dr. Damien Keogh, Founder & CEO, BluMaiden Biosciences
Dr. Damien Keogh is a molecular biologist turned entrepreneur who founded BluMaiden Biosciences, an AI-driven drug discovery company leveraging microbiome insights to identify novel therapeutics. He will share his experience building a deep tech biotech from the ground up and transitioning from bench science to venture creation.
Dr. Goh Wei Jiang, Co-Founder & CEO, Craft Health
Dr. Goh Wei Jiang is a pharmacist and NUS PhD graduate who co-founded Craft Health, a MedTech startup using 3D printing to produce personalised medicines. He will share his journey from clinical practice to entrepreneurship and the realities of spinning out a deep tech startup from academia.
About the Host:
Nucleate is a 501(c)(3) nonprofit organization dedicated to empowering the next generation of biotech leaders. With chapters spanning 41 geographic regions and participation from over 280 academic institutions, Nucleate sparks new intellectual communities and embeds emerging talent within a global biotech community. Through open-access educational programming, Nucleate helps democratize biotech innovation — removing barriers and helping founders concentrate on building transformational technologies. Visit www.nucleate.org for more information, and visit https://nucleate.org/privacy-policy/ to read our privacy policy.
We want to thank our HQ supporters for championing our open-access mission and empowering the next generation of biotech entrepreneurs!